1 – 20 of 588
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein (IL-1RAP) : A magic bullet candidate for immunotherapy of human malignancies
(
- Contribution to journal › Scientific review
-
Mark
Cancer-associated fibroblasts express CD1d and activate invariant natural killer T cells under cellular stress
(
- Contribution to journal › Letter
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
From master’s thesis to research publication : a mixed-methods study of medical student publishing and experiences with the publishing process
(
- Contribution to journal › Article
-
Mark
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
(
- Contribution to journal › Scientific review
-
Mark
Current and emerging sequencing-based tools for precision cancer medicine
(
- Contribution to journal › Scientific review
-
Mark
PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation
(
- Contribution to journal › Article
-
Mark
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
(
- Contribution to journal › Article
-
Mark
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC) : a pooled analysis of seven studies
(
- Contribution to journal › Article
-
Mark
Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma
2024) In Proceedings of the National Academy of Sciences of the United States of America 121(7). p.2310479121-2310479121(
- Contribution to journal › Article
-
Mark
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
(
- Contribution to journal › Article
-
Mark
Therapeutic potential of miR-379 in prostate cancer
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
(
- Contribution to journal › Article
-
Mark
Editorial : Celebration of DNA Day
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Development of celiac-safe foods : prevention of transglutaminase 2 (TG2) deamidation of gluten in healthy non-celiac volunteers
(
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
2024) European Association for Cancer Research(
- Contribution to conference › Poster
-
Mark
Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(
- Contribution to journal › Article